Top cited articles

Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial
Lopes, Maria Isabel; Bonjorno, Leticia P.; Giannini, Marcela C.; et al
10.1136/rmdopen-2020-001455

Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
Sattui, Sebastian Eduardo; Liew, Jean W.; Kennedy, Kevin; et al
10.1136/rmdopen-2021-001814

Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases
Hasseli, Rebecca; Mueller-Ladner, Ulf; Hoyer, Bimba F.; et al
10.1136/rmdopen-2020-001464

Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study
Lopez-Medina, Clementina; Molto, Anna; Sieper, Joachim; et al
10.1136/rmdopen-2020-001450

Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review
Taha, Muhanad; Samavati, Lobelia
10.1136/rmdopen-2021-001580

Humoral and cellular immune responses on SARS-CoV-2 vaccines in patients with anti-CD20 therapies: a systematic review and meta-analysis of 1342 patients
Schietzel, Simeon; Anderegg, Manuel; Limacher, Andreas; et al
10.1136/rmdopen-2021-002036

Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey
Ursini, Francesco; Ciaffi, Jacopo; Mancarella, Luana; et al
10.1136/rmdopen-2021-001735

Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1)
Garrido-Cumbrera, Marco; Marzo-Ortega, Helena; Christen, Laura; et al
10.1136/rmdopen-2020-001546

Digital rheumatology in the era of COVID-19: results of a national patient and physician survey
Kernder, Anna; Morf, Harriet; Klemm, Philipp; et al
10.1136/rmdopen-2020-001548

High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry
Lopes Marques, Claudia Diniz; Kakehasi, Adriana Maria; Pinheiro, Marcelo Medeiros; et al
10.1136/rmdopen-2020-001461

Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases
Furer, Victoria; Rondaan, Christien; Agmon-Levin, Nancy; et al
10.1136/rmdopen-2021-001594

Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry
Glintborg, Bente; Jensen, Dorte Vendelbo; Engel, Sara; et al
10.1136/rmdopen-2020-001505

Current view on the pathogenic role of anti-citrullinated protein antibodies in rheumatoid arthritis
Catrina, Anca; Krishnamurthy, Akilan; Rethi, Bence
10.1136/rmdopen-2020-001228

Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 study
McInnes, Iain B.; Kato, Koji; Magrey, Marina; et al
10.1136/rmdopen-2021-001838

All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015-2019
Bournia, Vasiliki-Kalliopi; Fragoulis, George E.; Mitrou, Panagiota; et al
10.1136/rmdopen-2021-001694

Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naive or TNF alpha inhibitor-experienced
Ritchlin, Christopher T.; Helliwell, Philip S.; Boehncke, Wolf-Henning; et al
10.1136/rmdopen-2020-001457

Efficacy and safety of colchicine in COVID-19: a meta-analysis of randomised controlled trials
Mehta, Kedar Gautambhai; Patel, Tejas; Chavda, Paragkumar D.; Patel, Parvati
10.1136/rmdopen-2021-001746

Humoral protection to SARS-CoV2 declines faster in patients on TNF alpha blocking therapies
Geisen, Ulf M.; Sumbul, Melike; Tran, Florian; et al
10.1136/rmdopen-2021-002008

Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study
Ramonda, Roberta; Lorenzin, Mariagrazia; Carriero, Antonio; et al
10.1136/rmdopen-2020-001519

CT-like images of the sacroiliac joint generated from MRI using susceptibility-weighted imaging (SWI) in patients with axial spondyloarthritis
Deppe, Dominik; Hermann, Kay-Geert; Proft, Fabian; et al
10.1136/rmdopen-2021-001656